143 related articles for article (PubMed ID: 20547636)
21. Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor?
Camani C; Gavin O; Kruithof EK
Thromb Haemost; 2000 Feb; 83(2):290-6. PubMed ID: 10739388
[TBL] [Abstract][Full Text] [Related]
22. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
Wilson MJ; Ludowese C; Sinha AA; Estensen RD
Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
[TBL] [Abstract][Full Text] [Related]
23. Stimulation of tissue-type plasminogen activator synthesis by retinoids in cultured human endothelial cells and rat tissues in vivo.
Kooistra T; Opdenberg JP; Toet K; Hendriks HF; van den Hoogen RM; Emeis JJ
Thromb Haemost; 1991 May; 65(5):565-72. PubMed ID: 1908141
[TBL] [Abstract][Full Text] [Related]
24. Production of tissue-type plasminogen activator (t-PA) and type-1 plasminogen activator inhibitor (PAI-1) in mildly cirrhotic rat liver.
Seki T; Imai H; Uno S; Ariga T; Gelehrter TD
Thromb Haemost; 1996 May; 75(5):801-7. PubMed ID: 8725727
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of chronic treatment with estrogen receptor ligands on regulation of nitric oxide synthase in porcine aortic endothelial cells.
Okano H; Jayachandran M; Yoshikawa A; Miller VM
J Cardiovasc Pharmacol; 2006 Apr; 47(4):621-8. PubMed ID: 16680078
[TBL] [Abstract][Full Text] [Related]
26. Effects of dydrogesterone and of its stable metabolite, 20-alpha-dihydrodydrogesterone, on nitric oxide synthesis in human endothelial cells.
Simoncini T; Caruso A; Giretti MS; Scorticati C; Fu XD; Garibaldi S; Baldacci C; Mannella P; Fornari L; Genazzani AR
Fertil Steril; 2006 Oct; 86(4 Suppl):1235-42. PubMed ID: 16963030
[TBL] [Abstract][Full Text] [Related]
27. Effect of Tisseel on expression of tissue plasminogen activator and plasminogen activator inhibitor-1.
Diamond MP; Kruger M; Saed GM
Fertil Steril; 2004 Jun; 81(6):1657-64. PubMed ID: 15193491
[TBL] [Abstract][Full Text] [Related]
28. Interactive effects of insulin-like growth factor-1 and beta-estradiol on endothelial nitric oxide synthase activity in rat aortic endothelial cells.
Isenovic ER; Divald A; Milivojevic N; Grgurevic T; Fisher SE; Sowers JR
Metabolism; 2003 Apr; 52(4):482-7. PubMed ID: 12701063
[TBL] [Abstract][Full Text] [Related]
29. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
Mehta VB; Zhou Y; Radulescu A; Besner GE
Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
[TBL] [Abstract][Full Text] [Related]
30. Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling.
Su KH; Tsai JY; Kou YR; Chiang AN; Hsiao SH; Wu YL; Hou HH; Pan CC; Shyue SK; Lee TS
Cardiovasc Res; 2009 Jun; 82(3):468-75. PubMed ID: 19307231
[TBL] [Abstract][Full Text] [Related]
31. Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells.
Fujii S; Lucore CL; Hopkins WE; Billadello JJ; Sobel BE
Thromb Haemost; 1990 Nov; 64(3):412-9. PubMed ID: 2128971
[TBL] [Abstract][Full Text] [Related]
32. EDF-1 contributes to the regulation of nitric oxide release in VEGF-treated human endothelial cells.
Leidi M; Mariotti M; Maier JA
Eur J Cell Biol; 2010 Sep; 89(9):654-60. PubMed ID: 20605058
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2.
Liu JW; Wei DZ; Du CB; Zhong JJ
Acta Pharmacol Sin; 2003 Feb; 24(2):102-8. PubMed ID: 12546716
[TBL] [Abstract][Full Text] [Related]
34. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
[TBL] [Abstract][Full Text] [Related]
35. Determinants of induction of increased synthesis of plasminogen activator inhibitor type-1 in human endothelial cells by t-PA.
Fujii S; Sobel BE
Thromb Haemost; 1992 Feb; 67(2):233-8. PubMed ID: 1621243
[TBL] [Abstract][Full Text] [Related]
36. Promotion of direct angiogenesis in vitro and in vivo by Puerariae flos extract via activation of MEK/ERK-, PI3K/Akt/eNOS-, and Src/FAK-dependent pathways.
Chung BH; Cho YL; Kim JD; Jo HS; Won MH; Lee H; Ha KS; Kwon YG; Kim YM
Phytother Res; 2010 Jun; 24(6):934-40. PubMed ID: 19960515
[TBL] [Abstract][Full Text] [Related]
37. Cellular actions of testosterone in vascular cells: mechanism independent of aromatization to estradiol.
Campelo AE; Cutini PH; Massheimer VL
Steroids; 2012 Sep; 77(11):1033-40. PubMed ID: 22728893
[TBL] [Abstract][Full Text] [Related]
38. Physiological effects of androgens on human vascular endothelial and smooth muscle cells in culture.
Nheu L; Nazareth L; Xu GY; Xiao FY; Luo RZ; Komesaroff P; Ling S
Steroids; 2011 Dec; 76(14):1590-6. PubMed ID: 22019845
[TBL] [Abstract][Full Text] [Related]
39. Rapid increase of spines by dihydrotestosterone and testosterone in hippocampal neurons: Dependence on synaptic androgen receptor and kinase networks.
Hatanaka Y; Hojo Y; Mukai H; Murakami G; Komatsuzaki Y; Kim J; Ikeda M; Hiragushi A; Kimoto T; Kawato S
Brain Res; 2015 Sep; 1621():121-32. PubMed ID: 25511993
[TBL] [Abstract][Full Text] [Related]
40. [Effects of sirolimus upon endothelial thrombotic function of human umbilical vein endothelial cells].
Nie XM; Zhou YJ; Li YF; Xie Y; Su LX
Zhonghua Yi Xue Za Zhi; 2011 May; 91(18):1281-4. PubMed ID: 21756803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
